PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma
- Conditions
- Glioblastoma
- Interventions
- Biological: PF-04856884
- First Posted Date
- 2010-10-21
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Pfizer
- Registration Number
- NCT01225510
Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)
- First Posted Date
- 2010-10-20
- Last Posted Date
- 2012-07-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 41
- Registration Number
- NCT01224626
Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- Other: Pristiq first-line treatment chartsOther: Pristiq second-line treatment chartsOther: SNRI or SSRI first-line treatment chartsOther: SNRI or SSRI second-line treatment charts
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2011-01-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2701
- Registration Number
- NCT01221935
Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2011-02-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 14
- Registration Number
- NCT01220232
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
NeisVac-C Single Prime Study in Infants
- Conditions
- Neisseria Meningitidis
- Interventions
- Biological: Meningococcal group C polysaccharide conjugate vaccineBiological: Pneumococcal 13-valent conjugate vaccineBiological: Combined Diphtheria-Tetanus-acellular Pertussis (DTPa), Hepatitis B, Poliovirus and Haemophilus influenzae type b vaccine
- First Posted Date
- 2010-10-11
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 956
- Registration Number
- NCT01218451
- Locations
- 🇵🇱
SPSK nr 1 we Wrocławiu, Klinika Pediatrii i Chorób Infekcyjnych, Wroclaw, Poland
🇵🇱Przychodnia Medycyny Wieku Rozwojowego, Poznan, Poland
🇵🇱Wojewodzki Specjalistyczny Szpital im. W. Bieganskiego, Oddzial Obserwacyjno-Zakazny dla Dzieci, Lodz, Poland
Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects
- Conditions
- Healthy
- Interventions
- Drug: 1 mgDrug: 5 mgDrug: 10 mg
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2011-02-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT01217918
- Locations
- 🇺🇸
Pfizer Investigational Site, Glendale, California, United States
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2012-08-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 218
- Registration Number
- NCT01216163
- Locations
- 🇺🇸
Pfizer Investigational Site, Salt Lake City, Utah, United States
Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins
- Conditions
- Invasive CandidiasisCandidemia
- Interventions
- Other: Does not apply
- First Posted Date
- 2010-10-04
- Last Posted Date
- 2016-03-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 536
- Registration Number
- NCT01213823
Scopolamine Challenge Study
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-10-04
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 38
- Registration Number
- NCT01213355
- Locations
- 🇫🇷
Pfizer Investigational Site, Rennes, France
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
- First Posted Date
- 2010-10-01
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1717
- Registration Number
- NCT01212991
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇺🇸North County Oncology Medical Clinic, Inc, Oceanside, California, United States
🇺🇸Levine Cancer Institute - Main, Charlotte, North Carolina, United States